Transparency Exchange News Today : Breaking News, Live Updates & Top Stories | Vimarsana

After covid19 vaccine. We are going to be talking in particular of an Innovative New model to try to address the issues around how to encourage accelerated research and development of important vaccine candidates, but also, how they can produced and distributed in ways that take an International Perspective and a perspective of equity and a Public Healthdriven distribution approach. So, were going to be talking a lot about the covax and theres a slide for the audience to get more grounded in what is covax. Its the vaccine pillar of something called the act accelerator to speed up access to dia...

We established the commission in 2018, it is extending its work in the midst of the intimate through the fall of 2022. These issues are central to the work. We are undertaking. Peggy, one of our commissioners, will be presiding. She recently stepped down from the National Academy of medicine, and was the president of the American Association for the advancement of science, and the former fda commissioner, and former Health Commissioner for the city of new york. We published an analysis that is a companion to this event. S it possible to avert chaos in the vaccine scramble . It is available at ...

Ral republican lawmakers have offered remarks to reporters. Heres a look. Its about the continuity of government. I believe the name that was on the list could carry out and keep government running. There is a question to make a question some people say mchenry has that power and some will say he doesnt have all the power. Should we allow mcheny ry have that power. I was speaking to matt gaetz and i told him to sit down and sat down. I think the entire conference the whole country is screaming at matt gaetz. Crazy eights led by matt gaetz. We have never been in this situation before. How you h...

Killed by the house commerce subcommittee on health with representatives from the pharmaceutical industry and policy stakeholders. This is three hours. [inaudible conversations] [inaudible conversations] we will come to order. The committee will come to order and the chair will recognize himself for an opening statement. Todays hearing is focus on the critical topic of finding longterm solutions to prevent future drug shortages of key drugs for patients. For months, Cancer Patients including pediatric Cancer Patients, have had to scramble to find the drugs recommended or use alternatives becau...

Subcommittee on health with representatives from the pharmaceutical industry and policy stakeholders. This is three hours. [inaudible conversations] [inaudible conversations] we will come to order. The committee will come to order and the chair will recognize himself for an opening statement. Todays hearing is focus on the critical topic of finding longterm solutions to prevent future drug shortages of key drugs for patients. For months, Cancer Patients including pediatric Cancer Patients, have had to scramble to find the drugs recommended or use alternatives because of instability in the mark...